The Effects of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Disease Risks in Type 2 Diabetes Mellitus by Pegah Yousefzadeh, Xiangbing Wang

“…To review the current literature investigating the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on the risk factors of cardiovascular disease (CVD). Methods. We conducted a search of PubMed and MEDLINE database, using the term DPP-4 inhibitor in combination with the following terms: metabolic syndrome, hypertension, dyslipidemia, insulin resistance, obesity, and CVD. …”
Get full text

Management of High Blood Pressure in Those without Overt Cardiovascular Disease Utilising Absolute Risk Scores by Mark R. Nelson

“…However, estimating absolute risk rather than measurement of a single risk factor such as blood pressure is a superior method to identify who is most at risk of having an adverse cardiovascular event such as stroke or myocardial infarction, and therefore who would most likely benefit from therapeutic intervention. Cardiovascular disease (CVD) risk calculators must be used to estimate absolute risk in those without overt CVD as physician estimation is unreliable. …”
Get full text

Cardiovascular Disease and Its Implication for Higher Catastrophic Health Expenditures Among Households in Sub-Saharan Africa by Folashayo Ikenna Peter Adeniji, Taiwo Akinyode Obembe

“…**Background:** Cardiovascular diseases (CVDs) impose an enormous and growing economic burden on households in sub-Saharan Africa (SSA). …”
Get full text

Sex differences in the associations of water, coffee and tea consumption with cardiovascular diseases: a prospective cohort study by Dandan Ke, Dandan Ke, Yueqing Wang, Yabing Hou, Weihao Shao, Jiawen Ke, Xiaoxuan Zhang, Hongxi Yang, Zhong He, Zuolin Lu

Subjects: Get full text

Comparison of 10-year atherosclerotic cardiovascular disease (ASCVD) risk in metropolitan and rural areas of South of Iran by Mohammad Javad Zibaeenezhad, Mehrab Sayadi, Hossein Pourmontaseri, Davood Khalili, Mojtaba Farjam, Ehsan Bahramail, Nader Parsa, Azizallah Dehghan, Seyyed Saeed Mohammadi, Iman Razeghian-Jahromi, Hamed Bazrafshan drissi, Matin Sepehrinia

Subjects: “…Atherosclerotic cardiovascular disease risk score…”
Get full text

Triglyceride-glucose-body mass index and the incidence of cardiovascular diseases: a meta-analysis of cohort studies by Xiyun Rao, Ziyi Xin, Qingwen Yu, Lanlan Feng, Yongmin Shi, Ting Tang, Xuhan Tong, Siqi Hu, Yao You, Shenghui Zhang, Jiake Tang, Xingwei Zhang, Mingwei Wang, Ling Liu

Subjects: Get full text

Physical activity parameters as determinants of cardiovascular disease risk in kidney transplant recipients: an accelerometer-based study by Hatice N. Bozkurt, Meriç Yıldırım, Caner Çavdar, Yelda D. Bildacı

Subjects: Get full text

Proprotein Convertase Subtilisin/Kexin Type 9: From the Discovery to the Development of New Therapies for Cardiovascular Diseases by Nicola Ferri

“…The identification of the HMG-CoA reductase inhibitors, statins, has represented a dramatic innovation of the pharmacological modulation of hypercholesterolemia and associated cardiovascular diseases. However, not all patients receiving statins achieve guideline-recommended low density lipoprotein (LDL) cholesterol goals, particularly those at high risk. …”
Get full text

The impact of dietary patterns on gut microbiota for the primary and secondary prevention of cardiovascular disease: a systematic review by Junwen Yu, Yue Wu, Zheng Zhu, Hongzhou Lu

Subjects: Get full text

The association between age at menarche (AAM) and cardiovascular disease (CVD) risk factors in the MASHAD cohort study by Niloofar Shabani, Sara Saffar Soflaei, Khadijeh Bavafa-Valenlia, Nayereh Esmaeilzadeh, Maryam Mohammadi-Bajgriran, Zahra Namazibaygi, Mohsen Moohebati, Gordon A. Ferns, Habibollah Esmaily, Majid Ghayour-Mobarhan

Subjects: Get full text

Unlocking the link: predicting cardiovascular disease risk with a focus on airflow obstruction using machine learning by Xiyu Cao, Jianli Ma, Xiaoyi He, Yufei Liu, Yang Yang, Yaqi Wang, Chuantao Zhang

Subjects: “…Cardiovascular disease…”
Get full text

Association between normal weight obesity and comorbidities and events of cardiovascular diseases among adults in South China by Miaomiao Ma, Deliang Lv, Xiaobing Wu, Yuqing Chen, Shimiao Dai, Yutian Luo, Hui Yang, Wei Xie, Fengzhu Xie, Qinggang Shang, Ziyang Zhang, Zhiguang Zhao, Ji-Chang Zhou

Get full text

Additive Effect of Sarcopenia and Anemia on the 10-Year Risk of Cardiovascular Disease in Patients with Type 2 Diabetes by Feihui Zeng, Lingning Huang, Yongze Zhang, Xinyu Hong, Suiyan Weng, Ximei Shen, Fengying Zhao, Sunjie Yan

“…To investigate the association between sarcopenia and anemia and the 10-year cardiovascular disease risk in diabetic patients. Methods. …”
Get full text

A prediction model for high-risk cardiovascular disease among residents aged 35 to 75 years by ZHOU Guoying，XING Lili，SU Ying，LIU Hongjie，LIU He，WANG Di，XUE Jinfeng，DAI Wei，WANG Jing，YANG Xinghua，

Subjects: “…cardiovascular disease…”
Get full text

Trends of cause-specific cardiovascular disease mortality in China, 2009-2019: a nationwide longitudinal study by Lu Wang, Yuzhu Wang, Zixiang Ji, Rongyu Zhu, Hengjing Wu, Jue Li, Liang Zheng, Lijuan Zhang

Subjects: “…Cardiovascular diseases…”
Get full text

Association of the abdominal aortic calcification with all-cause and cardiovascular disease-specific mortality: Prospective cohort study by Chang Sheng, Zhou Cai, Pu Yang

Get full text

The relationship of growth differentiation factor 15 with some biochemical parameters in cardiovascular disease patients in Babylon City by Hiba Resheed Behayaa, Zinah Abbass Ali, Seenaa Badr Mohammed, Suhayr A. Alqaysi

Subjects: Get full text

Cardiovascular diseases in patients with cancer: A comprehensive review of epidemiological trends, cardiac complications, and prognostic implications by Ali A. Alshahrani, Evangelos Kontopantelis, Catharine Morgan, Rathi Ravindrarajah, Glen P. Martin, Mamas A. Mamas, Rongman Jia

“…This article provides an overview of the current evidence on the epidemiology, overlapping risk factors, and pathophysiology of cardiovascular disease (CVD) in patients with cancer. It explores the cardiotoxic effects of anticancer therapy and their impact on prognosis. …”
Get full text

Impaired Glucose Metabolism Is Associated with Visit-to-Visit Blood Pressure Variability in Participants without Cardiovascular Disease by Nobuo Sasaki, Ryoji Ozono, Saeko Fujiwara, Ryo Maeda, Yasuki Kihara

“…We evaluated data from 10,088 participants without cardiovascular disease (CVD) who underwent 75 g oral glucose tolerance tests and had more than four visits during the first 5 years following the test to investigate the association between impaired glucose metabolism and visit-to-visit blood pressure (BP) variability. …”
Get full text

Association between normal weight obesity and comorbidities and events of cardiovascular diseases among adults in South China. by Miaomiao Ma, Deliang Lv, Xiaobing Wu, Yuqing Chen, Shimiao Dai, Yutian Luo, Hui Yang, Wei Xie, Fengzhu Xie, Qinggang Shang, Ziyang Zhang, Zhiguang Zhao, Ji-Chang Zhou

“…<h4>Background</h4>The increased risks for cardiovascular comorbidities and cardiovascular diseases (CVD) in populations with normal weight obesity (NWO) have not been well-identified. …”
Get full text